Literature DB >> 24089568

5-HT2 receptors facilitate JC polyomavirus entry.

Benedetta Assetta1, Melissa S Maginnis, Irene Gracia Ahufinger, Sheila A Haley, Gretchen V Gee, Christian D S Nelson, Bethany A O'Hara, Stacy-ann A Allen Ramdial, Walter J Atwood.   

Abstract

The human JC polyomavirus (JCPyV) causes the rapidly progressing demyelinating disease progressive multifocal leukoencephalopathy (PML). The disease occurs most often in individuals with AIDS but also occurs in individuals receiving immunomodulatory therapies for immune-related diseases such as multiple sclerosis. JCPyV infection of host cells requires the pentasaccharide lactoseries tetrasaccharide c (LSTc) and the serotonin receptor 5-hydroxytryptamine (5-HT) receptor 5-HT2AR. While LSTc is involved in the initial attachment of virus to cells via interactions with VP1, the mechanism by which 5-HT2AR contributes to infection is not clear. To further define the roles of serotonin receptors in infection, HEK293A cells, which are poorly permissive to JCPyV, were transfected with 14 different isoforms of serotonin receptor. Only 5-HT2 receptors were found to support infection by JCPyV. None of the other 11 isoforms of serotonin receptor supported JCPyV infection. Expression of 5-HT2 receptors did not increase binding of JCPyV to cells, but this was not unexpected, given that the cells uniformly expressed the major attachment receptor, LSTc. Infection of these cells remained sensitive to inhibition with soluble LSTc, confirming that LSTc recognition is required for JCPyV infection. Virus internalization into HEK293A cells was significantly and specifically enhanced when 5HT2 receptors were expressed. Taken together, these data confirm that the carbohydrate LSTc is the attachment receptor for JCPyV and that the type 2 serotonin receptors contribute to JCPyV infection by facilitating entry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24089568      PMCID: PMC3838264          DOI: 10.1128/JVI.02252-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Further evidence that papillomavirus capsids exist in two distinct conformations.

Authors:  Hans-Christoph Selinka; Tzenan Giroglou; Thorsten Nowak; Neil D Christensen; Martin Sapp
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Pathogens use structural mimicry of native host ligands as a mechanism for host receptor engagement.

Authors:  Nir Drayman; Yair Glick; Orly Ben-nun-shaul; Hagit Zer; Adam Zlotnick; Doron Gerber; Ora Schueler-Furman; Ariella Oppenheim
Journal:  Cell Host Microbe       Date:  2013-07-17       Impact factor: 21.023

3.  JC virus infection in cells from lymphoid tissue.

Authors:  M C Monaco; J Shin; E O Major
Journal:  Dev Biol Stand       Date:  1998

4.  Junction adhesion molecule is a receptor for reovirus.

Authors:  E S Barton; J C Forrest; J L Connolly; J D Chappell; Y Liu; F J Schnell; A Nusrat; C A Parkos; T S Dermody
Journal:  Cell       Date:  2001-02-09       Impact factor: 41.582

Review 5.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

6.  The human polyomavirus, JCV, does not share receptor specificity with SV40 on human glial cells.

Authors:  C K Liu; A P Hope; W J Atwood
Journal:  J Neurovirol       Date:  1998-02       Impact factor: 2.643

7.  JC virus antibody status underestimates infection rates.

Authors:  Joseph R Berger; Sidney A Houff; Julie Gurwell; Nubia Vega; Craig S Miller; Robert J Danaher
Journal:  Ann Neurol       Date:  2013-08-06       Impact factor: 10.422

Review 8.  Molecular biology of serotonin (5-HT) receptors.

Authors:  S J Peroutka
Journal:  Synapse       Date:  1994-11       Impact factor: 2.562

9.  Quantification of human polyomaviruses JC Virus and BK Virus by TaqMan quantitative PCR and comparison to other water quality indicators in water and fecal samples.

Authors:  Shannon M McQuaig; Troy M Scott; Jerzy O Lukasik; John H Paul; Valerie J Harwood
Journal:  Appl Environ Microbiol       Date:  2009-04-03       Impact factor: 4.792

10.  Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.

Authors:  A Miyake; S Mochizuki; Y Takemoto; S Akuzawa
Journal:  Mol Pharmacol       Date:  1995-09       Impact factor: 4.436

View more
  44 in total

1.  Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.

Authors:  Ellen M Bouma; Denise P I van de Pol; Ilson D Sanders; Izabela A Rodenhuis-Zybert; Jolanda M Smit
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  The Greater Affinity of JC Polyomavirus Capsid for α2,6-Linked Lactoseries Tetrasaccharide c than for Other Sialylated Glycans Is a Major Determinant of Infectivity.

Authors:  Luisa J Ströh; Melissa S Maginnis; Bärbel S Blaum; Christian D S Nelson; Ursula Neu; Gretchen V Gee; Bethany A O'Hara; Nasim Motamedi; Daniel DiMaio; Walter J Atwood; Thilo Stehle
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

3.  Susceptibility of Primary Human Choroid Plexus Epithelial Cells and Meningeal Cells to Infection by JC Virus.

Authors:  Bethany A O'Hara; Gretchen V Gee; Walter J Atwood; Sheila A Haley
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

4.  Serotonin Receptor Agonist 5-Nonyloxytryptamine Alters the Kinetics of Reovirus Cell Entry.

Authors:  Bernardo A Mainou; Alison W Ashbrook; Everett Clinton Smith; Daniel C Dorset; Mark R Denison; Terence S Dermody
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

5.  GRK2 mediates β-arrestin interactions with 5-HT2 receptors for JC polyomavirus endocytosis.

Authors:  Colleen L Mayberry; Michael P Wilczek; Tristan M Fong; Sarah L Nichols; Melissa S Maginnis
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

Review 6.  Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.

Authors:  S A Misbah
Journal:  Clin Exp Immunol       Date:  2017-03-27       Impact factor: 4.330

7.  Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.

Authors:  Laura Riva; Ok-Ryul Song; Jannick Prentoe; François Helle; Laurent L'homme; Charles-Henry Gattolliat; Alexandre Vandeputte; Lucie Fénéant; Sandrine Belouzard; Thomas F Baumert; Tarik Asselah; Jens Bukh; Priscille Brodin; Laurence Cocquerel; Yves Rouillé; Jean Dubuisson
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

8.  JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.

Authors:  Colleen L Mayberry; Ashley N Soucy; Conner R Lajoie; Jeanne K DuShane; Melissa S Maginnis
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

9.  Adipocyte Plasma Membrane Protein (APMAP) promotes JC Virus (JCPyV) infection in human glial cells.

Authors:  Sheila A Haley; Bethany A O'Hara; Walter J Atwood
Journal:  Virology       Date:  2020-06-07       Impact factor: 3.616

10.  Gallic acid-based small-molecule inhibitors of JC and BK polyomaviral infection.

Authors:  Bethany A O'Hara; Chamila Rupasinghe; Achani Yatawara; Gabriel Gaidos; Dale F Mierke; Walter J Atwood
Journal:  Virus Res       Date:  2014-06-21       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.